The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinoma.
Wang C, Dong L, Li X, Li Y, Zhang B, Wu H, Shen B, Ma P, Li Z, Xu Y, Chen B, Pan S, Fu Y, Huo Z, Jiang H, Wu Y, Ma Y.
Wang C, et al. Among authors: jiang h.
Free Radic Biol Med. 2021 Feb 1;163:141-152. doi: 10.1016/j.freeradbiomed.2020.11.035. Epub 2020 Dec 1.
Free Radic Biol Med. 2021.
PMID: 33276082
Free article.